Sajith Wickramasekara, Benchling’s CEO and co-founder. Eight months after enabling its R&D cloud to support FDA-regulated work done in later stages of biopharma product development, Benchling has ...

You're currently following this author! Want to unfollow? Unsubscribe via the link in your email. Follow Rosalie Chan Every time Rosalie publishes a story, you’ll get an alert straight to your inbox!

SAN FRANCISCO, Jan. 8, 2026 /PRNewswire/ -- Benchling, the platform for scientific progress, today announced a strategic collaboration with Lilly TuneLab, an artificial intelligence and machine ...

During the COVID-19 pandemic, scientists around the world rushed to create vaccines for the virus using mRNA technology. The pandemic showed the importance of quickly developing new therapeutics for a ...

SAN FRANCISCO, June 11, 2024 /PRNewswire/ -- Benchling, the R&D Cloud powering the biotech industry, today announced that global pharmaceutical company Sanofi is using Benchling across more than 1,500 ...

Benchling is a next-gen laboratory informatics platform that is helping life science companies manage increasingly complex data workflows. GEN Edge talks to CEO/co-founder Saji Wickramasekara and ...

Benchling, which develops software tools for scientists and pharmaceutical research organizations, has confidentially submitted paperwork with regulators for a stock market listing in New York, ...

Benchling, the leading life sciences R&D cloud platform, today announced the launch of Benchling for Lab Automation, a new solution to help life sciences companies maximize lab automation investments.